Mariza Daras, MD
Specialties: Adult brain tumors, including brain metastases
Dr. Daras is a neuro-oncologist specializing in the care of adults with brain tumors, including primary brain tumors like gliomas and meningiomas, as well as brain metastases. Dr. Daras leads the Brain Metastases Clinic at the BTC and has significant experience in the diagnosis and treatment of metastasis to the central nervous system.
Dr. Daras' research focuses on therapeutic trials for both metastatic and primary brain tumors. She is also interested in developing the use of advanced imaging techniques to guide treatment and/or detect early tumor progression as more targeted therapies and immunotherapies transition to clinic.
2003: BA, Biochemistry and Molecular Biology, New York University
2008: MD, Columbia University
2008-2009: Intern, Department of Medicine, Duke University Medical Center
2009-2012: Resident, Department of Neurology, Duke University Medical Center
2012-2014: Clinical Fellow, Department of Neurology, Memorial Sloan Kettering Cancer Center
2014-2019: Attending Physician, Neuro-Oncology, Memorial Sloan Kettering Cancer Center
2008: Medical Student Travel Grant, American Neurologic Association
2006: UCL Graduate School Masters Award
2003: University Honors Scholar, New York University
2003: Faculty Memorial Award, New York University
2003: Isidore Rubiner Award in Chemistry, New York University
2003: George Granger Brown Award in Chemistry, New York University
Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers.
Offin M, Feldman D, Ni A, Myers ML, Lai WV, Pentsova E, Boire A, Daras M, Jordan EJ, Solit DB, Arcila ME, Jones DR, Isbell JM, Beal K, Young RJ, Rudin CM, Riely GJ, Drilon A, Tabar V, DeAngelis LM, Yu HA, Kris MG, Li BT.
Cancer. 2019 Aug 30. doi: 10.1002/cncr.32461. [Epub ahead of print]
Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.
Jonsson P, Lin AL, Young RJ, DiStefano NM, Hyman DM, Li BT, Berger MF, Zehir A, Ladanyi M, Solit DB, Arnold AG, Stadler ZK, Mandelker D, Goldberg ME, Chmielecki J, Pourmaleki M, Ogilvie SQ, Chavan SS, McKeown AT, Manne M, Hyde A, Beal K, Yang TJ, Nolan CP, Pentsova E, Omuro A, Gavrilovic IT, Kaley TJ, Diamond EL, Stone JB, Grommes C, Boire A, Daras M, Piotrowski AF, Miller AM, Gutin PH, Chan TA, Tabar VS, Brennan CW, Rosenblum M, DeAngelis LM, Mellinghoff IK, Taylor BS.
Clin Cancer Res. 2019 Sep 15;25(18):5537-5547. doi: 10.1158/1078-0432.CCR-19-0032. Epub 2019 Jul 1.
Sequencing and curation strategies for identifying candidate glioblastoma treatments.
Frank MO, Koyama T, Rhrissorrakrai K, Robine N, Utro F, Emde AK, Chen BJ, Arora K, Shah M, Geiger H, Felice V, Dikoglu E, Rahman S, Fang A, Vacic V, Bergmann EA, Vogel JLM, Reeves C, Khaira D, Calabro A, Kim D, Lamendola-Essel MF, Esteves C, Agius P, Stolte C, Boockvar J, Demopoulos A, Placantonakis DG, Golfinos JG, Brennan C, Bruce J, Lassman AB, Canoll P, Grommes C, Daras M, Diamond E, Omuro A, Pentsova E, Orange DE, Harvey SJ, Posner JB, Michelini VV, Jobanputra V, Zody MC, Kelly J, Parida L, Wrzeszczynski KO, Royyuru AK, Darnell RB.
BMC Med Genomics. 2019 Apr 25;12(1):56. doi: 10.1186/s12920-019-0500-0.